Complications of Cushing's syndrome: state of the art
R Pivonello, AM Isidori, MC De Martino… - The lancet Diabetes & …, 2016 - thelancet.com
Cushing's syndrome is a serious endocrine disease caused by chronic, autonomous, and
excessive secretion of cortisol. The syndrome is associated with increased mortality and …
excessive secretion of cortisol. The syndrome is associated with increased mortality and …
The treatment of Cushing's disease
R Pivonello, M De Leo, A Cozzolino… - Endocrine …, 2015 - academic.oup.com
Abstract Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe
endocrine disease caused by a corticotroph pituitary tumor and associated with increased …
endocrine disease caused by a corticotroph pituitary tumor and associated with increased …
Treatment of Cushing's syndrome: an endocrine society clinical practice guideline
LK Nieman, BMK Biller, JW Findling… - The Journal of …, 2015 - academic.oup.com
Objective: The objective is to formulate clinical practice guidelines for treating Cushing's
syndrome. Participants: Participants include an Endocrine Society-appointed Task Force of …
syndrome. Participants: Participants include an Endocrine Society-appointed Task Force of …
Cushing's syndrome
Chronic exposure to excess glucorticoids results in diverse manifestations of Cushing's
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …
Cushing's syndrome: epidemiology and developments in disease management
ST Sharma, LK Nieman, RA Feelders - Clinical epidemiology, 2015 - Taylor & Francis
Cushing's syndrome is a rare disorder resulting from prolonged exposure to excess
glucocorticoids. Early diagnosis and treatment of Cushing's syndrome is associated with a …
glucocorticoids. Early diagnosis and treatment of Cushing's syndrome is associated with a …
Metabolic comorbidities in Cushing's syndrome
F Ferrau, M Korbonits - European Journal of Endocrinology, 2015 - academic.oup.com
Cushing's syndrome (CS) patients have increased mortality primarily due to cardiovascular
events induced by glucocorticoid (GC) excess-related severe metabolic changes. Glucose …
events induced by glucocorticoid (GC) excess-related severe metabolic changes. Glucose …
Advances in the medical treatment of Cushing's syndrome
Cushing's syndrome is associated with multisystem morbidity and, when suboptimally
treated, increased mortality. Medical therapy is an option for patients if surgery is not …
treated, increased mortality. Medical therapy is an option for patients if surgery is not …
Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review
K Ritzel, F Beuschlein, A Mickisch… - The Journal of …, 2013 - academic.oup.com
Background: The outcome of bilateral adrenalectomy (BADx) in patients with Cushing's
syndrome (CS) is not well characterized. Methods: A literature search was performed with …
syndrome (CS) is not well characterized. Methods: A literature search was performed with …
Transcriptional bursting and co-bursting regulation by steroid hormone release pattern and transcription factor mobility
Genes are transcribed in a discontinuous pattern referred to as RNA bursting, but the
mechanisms regulating this process are unclear. Although many physiological signals …
mechanisms regulating this process are unclear. Although many physiological signals …
Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment
LT Braun, G Rubinstein, S Zopp, F Vogel… - Endocrine, 2020 - Springer
Purpose Recurrence after pituitary surgery in Cushing's disease (CD) is a common problem
ranging from 5%(minimum) to 50%(maximum) after initially successful surgery, respectively …
ranging from 5%(minimum) to 50%(maximum) after initially successful surgery, respectively …